Skip to content

Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor

Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00930410
Acronym
EMID
Enrollment
50
Registered
2009-06-30
Start date
2008-09-30
Completion date
2012-05-31
Last updated
2013-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Diseases, Pancreas Neoplasms

Keywords

pancreas neoplasms, bile duct diseases, Cholangiopancreatography, Endoscopic Retrograde, ERCP

Brief summary

The endomicroscopy is an adaptation of traditional optical microscopy in the digestive endoscopy. Furthermore, with the integration of a miniaturized laser confocal microscope to a videoendoscope, it's possible to study the digestive mucous by optical biopsy. This monocentric, non randomized and prospective study uses the Intra-ductal confocal endomicroscopy for the characterization of pancreas and bile duct tumor.

Detailed description

Primary objective: Obtain a tissular characterization of a biliary or pancreatic stenosis with a confocal microscope which is in direct contact of the stenosis during the Endoscopic Retrograde Cholangio-Pancreatography (ERCP). Secondary objectives: * Compare the result of this optical biopsy to a conventional biopsy. * Tolerance

Interventions

Utilisation of the Intra-ductal confocal endomicroscopy to obtain any exploitable image for the anatomopathology.

Sponsors

Institut Paoli-Calmettes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged from 18 to older * Patient with an inflammatory or tumoral stenosis of bile duct or a solid or cystic tumor in the pancreas with a dilatation of the principal pancreatic canal. * Signed consent Non inclusion Criteria: * Patient who have no indication for an ERCP * Allergy to fluorescein * Allergic rhinitis, asthma, eczema * Pregnancy, breast feeding * Patients with dialysis * Patient with severe heart failure * Patient with cirrhosis * Hemostasis failure which can induce difficulties or contraindication for the biopsy during the conventional endoscopy

Design outcomes

Primary

MeasureTime frame
The principal outcome is the percentage of successful in vivo examination according to the localisation of the stenosis. A successful examination is defined by the obtention of exploitable image for the anatomopathology.2 days

Secondary

MeasureTime frame
Study of the concordance between optical and histological biopsy2 days
Frequency and grade of adverse effects induced by the confocal endomicroscopy2 days

Countries

France, Monaco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026